NRX Pharmaceuticals Inc - NRX-101 Is First Oral Antidepressant to Show 33% Advantage in Sustained Remission in Suicidality
NRX Pharmaceuticals Inc-NRX-101 是第一款在持續緩解自殺方面顯示出 33% 優勢的口服抗抑鬱藥
NRX Pharmaceuticals Inc - NRX-101 Is First Oral Antidepressant to Show 33% Advantage in Sustained Remission in Suicidality
NRX Pharmaceuticals Inc-NRX-101 是第一款在持續緩解自殺方面顯示出 33% 優勢的口服抗抑鬱藥
使用瀏覽器的分享功能,分享給你的好友吧